Epidemiology and risk factors for ebola virus disease in Sierra Leone - 23 May 2014 to 31 January 2015

Clinical Infectious Diseases

Volumn 61, Issue 11, 2015, Pages 1648-1654

  Dietz, Patricia M ^a   Jambai, Amara ^b   Paweska, Janusz T ^c   Yoti, Zabulon ^d   Ksaizek, Thomas G ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Sierra Leone Ministry of Health   (United States)

^c NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Ebola; epidemiology; Filoviridae.; Sierra Leone; surveillance

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTHRALGIA; BLEEDING; CHILD; CONFUSION; CONJUNCTIVITIS; CONTROLLED STUDY; COUGHING; DIARRHEA; DYSPHAGIA; EBOLA HEMORRHAGIC FEVER; FATIGUE; FEMALE; FEVER; HEADACHE; HICCUP; HUMAN; INCIDENCE; INFECTION RISK; JAUNDICE; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYALGIA; PRIORITY JOURNAL; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIERRA LEONE; SORE THROAT; VOMITING; WEAKNESS; DISEASE OUTBREAKS; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; HEMORRHAGIC FEVER, EBOLA; RISK FACTOR; TIME FACTOR; TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; DIARRHEA; DISEASE OUTBREAKS; EPIDEMICS; EPIDEMIOLOGICAL MONITORING; FEMALE; FEVER; HEMORRHAGIC FEVER, EBOLA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SIERRA LEONE; TIME FACTORS; YOUNG ADULT;

EID: 84947981325     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ568     Document Type: Review

References (13)

1. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371:1418-25.
2. Government of Sierra Leone, Ministry of Health and Sanitation. Ebola virus disease-situation report (Sit-Rep) 2 February 2015 Available at http://health.gov.sl/wp-content/uploads/2015/02/Ebola-Situation-Report-Vol-249.pdf. Accessed 26 May 2015.
3. WHO Ebola Response Team. Ebola virus disease in West Africa: the first 9 months of the epidemic and forward projections. N Engl J Med 2014; 371:1481-95.
4. World Health Organization. Ebola and Marburg virus disease epidemics: preparedness, alert, control, and evaluation. Interim manual version 1. 2. 2014. Available at: http://www.who.int/csr/disease/ebola/manual-EVD/en. Accessed 4 November 2014.
5. Ksiazek TG, West CP, Rollin PE, et al. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 1999; 179(suppl 1):S192.
6. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78:4330-41.
7. United Nations, Department of Economic and Social Affairs, Population Division, Population Estimates and Projections Section. World population prospects: the 2012 revision Available at http://esa. un.org/unpd/wpp/Excel-Data/population.htm. Accessed 4 November 2014.
8. Lamunu M, Lutwama JJ, Amugisha J, et al. Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001). Int J Infect Dis 2004; 8:27-37.
9. Okware SI, Omaswa FG, Zaramba S, et al. An outbreak of Ebola in Uganda. Trop Med Int Health 2002; 7:1068-75.
10. Breman JG, Johnson KM. Ebola then and now. N Engl J Med 2014; 371:1663-6.
11. Bausch DG, Schwarz L. Outbreak of Ebola virus disease in Guinea: where ecology meets economy. PloS Negl Trop Dis 2014; 8:e3056.
12. Davtyan M, Brown B, Folayan MO. Addressing Ebola-related stigma: lessons learned from HIV/AIDS. Glob Health Action 2014; 7:26058.
13. Meltzer M, Atkins CY, Santibanez S, et al. Estimating the future number of cases in the Ebola epidemic-Liberia and Sierra Leone, 2014-2015. MMWR Morb Mortal Wkly Rep 2014; 63:1-14.